Sanofi-Aventis, Genzyme Are on the Brink of a Merger

It seems that months of merger talks between French pharma Sanofi-Aventis and U.S. biotech Genzyme have entered the home stretch. This week, Sanofi is expected to offer $74 a share for Genzyme, with an option included potential…

BJ’s Wholesale Club Surges After Saying Company May Be Sold

Retailer BJ’s Wholesale Club (BJ) jumped in premarket trading after announcing that it is considering putting itself up for sale.

The stock jumped 13.35% to $48.74 a share at 8:12 am ET.

BJ’s has hired Morgan Stanley & Co. (MS) to advise on opt…

Just How Much Is Sanofi Aventis Offering for Genzyme?

Just after Genzyme announced that it signed a confidentiality agreement with Sanofi Aventis to allow the French drugmaker to examine its books, leaks about the potential deal started pouring out. The numbers and details vary, s…

European Commission Approves Intel Acquisition of McAfee

The European Commission on Wednesday approved Intel’s $7.68 billion acquisition of security-software company McAfee. Regulators had been concerned that the deal would exclude competing software from working with Intel processor…